series-a
Stage
4
Investors
About
Serna Bio is an AI-enabled drug discovery company focused on developing small molecules that target RNA to treat diseases with high unmet medical need. The company leverages synthetic biology, machine learning, and multiplex screening to design selective small molecules targeting untapped biology in the transcriptome.
Explore Serna Bio's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.